|
|
| Research article summary (published 29 Sep 2009): |
Is elevated noradrenaline an aetiological factor in a number of diseases?
Full Abstract
1 Here I put forth the hypothesis that noradrenaline (NA), which is a signalling molecule in the brain and sympathetic nervous system (SNS), is an aetiological factor in a number of diseases. 2 In a previous paper (Fitzgerald, Int. J. Cancer, 124, 2009, 257), I examined evidence that elevated NA is a factor in various types of cancer. Here I extend the argument to several other diseases, including diabetes mellitus, open-angle glaucoma, osteoarthritis and rheumatoid arthritis and asthma. 3 The principal hypothesis is that, largely as a result of genetics, elevated noradrenergic tone in the SNS predisposes a large number of individuals to a broad range of diseases. 4 For each of the above five diseases, I briefly examine the following four lines of evidence to assess the hypothesis: i) whether pharmacological studies in rodents that manipulate NA levels or receptors affect these diseases; ii) whether pharmacological manipulation of NA in humans affects these diseases; iii) whether bipolar disorder, excessive body weight, and hypertension, which may all three involve elevated NA, tend to be comorbid with these diseases and iv) whether psychological stressors tend to cause or exacerbate these conditions, since psychological stress is associated with increased release of NA. 5 The four lines of evidence tend to support the hypothesis.
Author information
Author/s: Fitzgerald, P J (PJ);
Affiliation: The Zanvyl Krieger Mind/Brain Institute, Solomon H. Snyder Department of Neuroscience, Johns Hopkins University, 338 Krieger Hall, 3400 N Charles St, Baltimore, MD 21218, USA.
Journal and publication information
Publication Type: Journal Article; Review
Journal: Autonomic & autacoid pharmacology (Auton Autacoid Pharmacol), published in England. (Language: eng)
Reference: 2009-Oct; vol 29 (issue 4) : pp 143-56
Dates: Created 2009/09/10; Completed 2009/11/13;
PMID: 19740085, status: MEDLINE (last retrieved date: 11/15/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Norepinephrine (51-41-2)Related articles
These are the most related articles currently in our database:
- Role of the NF-kappaB pathway in the pathogenesis of human disease states.
29 Jun 2001 - Gene-environment interaction in complex diseases: asthma as an illustrative case.
30 Dec 2007 - Sugar and disease.
30 Oct 1979 - [Lysophosphatidic acid: a "bioactive" phospholipid]
30 Jul 2004 - Structure and function of the plasminogen/plasmin system.
30 Mar 2005 - The thrombopoietic factor, Mpl-ligand.
30 May 1998 - Role of cellular magnesium in health and human disease.
30 Dec 2003 - Delving into the diversity of silencing pathways. Symposium on MicroRNAs and siRNAs: biological functions and mechanisms.
27 Jun 2007 - O-acetylation of sialic acids.
30 Dec 1997 - Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
2 Oct 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.